Search Results - "Atuğ, Ö"

P322 Hepatitis B reactivation under biologic therapy in patients with HBsAg negative phase of chronic HBV infection by Ergenç, I, Kani, H T, Karabacak, M, Cömert Özer, E, Mehdiyev, S, Jafarov, F, Abacar, K Y, Kutluğ Ağaçkıran, S, Seven Sevik, G, Alibaz Öner, F, İnanç, N, Atagündüz, M P, Gençosmanoğlu, D S, Özen Alahdab, Y, Ergun, T, Direskeneli, R H, Atuğ, Ö

“…Abstract Background Biologic agents are widely used in immune mediated inflammatory diseases (IMID). The risk and consequences of hepatitis B reactivation in…”
Get full text

P401 Anti-TNF treatments in Crohn's disease and improvement in work productivity and quality of life: an observational study from Turkey by Törüner, M., Başaranoğlu, M., Atuğ, Ö., Şentürk, Ö., Akyüz, F., Ünsal, B., Över Hamzaoğlu, H., Tekin, F., Sezgin, O., Akpınar, H., Çelik, A.F., Tezel, A., Göktürk, H.S., Kav, T.

Get full text

The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease by Yanartas, O, Kani, H T, Bicakci, E, Kilic, I, Banzragch, M, Acikel, C, Atug, O, Kuscu, K, Imeryuz, N, Akin, H

“…Depression and anxiety are common disorders in inflammatory bowel disease (IBD). Our aim is to prospectively determine the effect of psychiatric treatment on…”
Get full text

Association between the presence of brown adipose tissue and non‐alcoholic fatty liver disease in adult humans by Yilmaz, Y., Ones, T., Purnak, T., Ozguven, S., Kurt, R., Atug, O., Turoglu, H. T., Imeryuz, N.

“…Aliment Pharmacol Ther 2011; 34: 318–323 Summary Background  The presence of active brown adipose tissue (BAT) has been associated with a reduced risk of…”
Get full text

P159 - Ulcerative colitis might prevent colonic diverticulosis by Yönal, O., Ilhan, S., Atuğ, Ö., Över Hamzaoglu, H.

Get full text

1333 PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE by Eren, F, Kurt, R, Ermis, F, Atug, O, Imeryuz, N, Yilmaz, Y

Get full text

P035 - Attenuated response to purified protein derivative test in patients with inflammatory bowel disease by Kedrah, A.E., Alahdab, Y., Atuğ, Ö., Aydin, S., Imeryüz, N., Hamzaoglu, H. Över

Get full text

P022 - Attenuated response to purified protein derivative test in patients with inflammatory bowel disease by Kedrah, A.E., Alahdab, Y., Atuğ, Ö., Aydin, S., Imeryüz, N., Hamzaoğlu, H.

Get full text

Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity by Yilmaz, Y., Yonal, O., Eren, F., Atug, O., Over Hamzaoglu, H.

“…Interaction of the receptor for advanced glycation endproducts (RAGE) with its ligands results in expression of inflammatory mediators, activation of NF-κB,…”
Get full text

P236 - MEFV mutations modify the disease severity of inflammatory bowel disease by Barghi, I., Eren, F., Atuğ, Ö., Imeryüz, N., Atagunduz, P., Direskeneli, H., Tozun, N., Över Hamzaoglu, H.

Get full text

Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population by Alahdab, Y. O., Eren, F., Giral, A., Gunduz, F., Kedrah, A. E., Atug, O., Yilmaz, Y., Kalayci, O., Kalayci, C.

“…Background  C‐kit‐positive interstitial cells of Cajal (ICC) of the lower esophageal sphincter are reduced in achalasia. Two functional gene polymorphisms…”
Get full text

1034 PLASMA LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (SRAGE) IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE by Yilmaz, Y, Ulukaya, E, Gul, O.O, Arabul, M, Gul, C.B, Atug, O, Oral, A.Y, Dolar, E

Get full text

280 EFFECT OF LYE (NaOH) EXPOSURE ON THE PERMEABILITY OF RABBIT ESOPHAGEAL EPITHELIUM by Atug, O., Dobrucali, A. M., Tobey, N. A., Orlando, R. C.

“…Aim/BackgroundWe previously reported that lye (NaOH) injury (Gastroenterology 1991;100:A128) to esophageal epithelium was time and concentration dependent, as…”
Get full text

121 THE CALCIUM-INDEPENDENT COMPONENT OF THE SHUNT PATHWAY IN RABBIT ESOPHAGEAL EPITHELIUM by Tobey, N. A., Vanegas, X., Atug, O., Sempruin-Prieto, L., Orlando, R. C.

“…Aim/BackgroundWe previously reported that exposure of rabbit esophageal epithelium (EE) in Ussing chambers to calcium-free solution reduces the transepithelial…”
Get full text

P099 Evaluation of endoscopic mayo score with an artificial intelligence algorithm by Kani, H T, Ergenc, I, Polat, G, Ozen Alahdab, Y, Temizel, A, Atug, O

“…Abstract Background Multi-layered convolutional neural networks are artificial intelligence (AI) algorithms that allow to process specific datasets. Endoscopic…”
Get full text

120 CONTRIBUTORS TO ANION TRANSPORT IN HUMAN ESOPHAGEAL STRATIFIED SQUAMOUS EPITHELIUM AND BARRETT'S ESOPHAGUS by Tobey, N. A., Argote, C. M., Kav, T., Vanegas, X., Atug, O., Semprun-Prieto, L., Barlow, W., Orlando, R. C.

“…Aim/BackgroundWe previously reported that esophageal epithelium (EE), both stratified squamous (SS) and Barrett's (BE), from pinch biopsies could be mounted…”
Get full text

P1131 Epidemiological Characteristics of Inflammatory Bowel Diseases in The Last Decade: Multi-Center Türkiye Data by Akyuz, F, Agargun, B F, Atug, O, Eskazan, T, Yuksel, I, Kochan, K, Barutcu, S, Asil, M, Demirtas, C, Bozkurt, B, Cankurtaran, E, Degirmenci, A, Kefeli, A, Ustaoglu, M, Keskin, M K, Sahin, M, Ucer, M, Erurker Ozturk, T, Dervis Hakim, G, Uyanikoglu, A, Poturoglu, S, Kalkan, I H, Gulten, M, Arhan, M, Kav, T, Toruner, M, Akpinar, H, Issever, H, Celik, A F

“…Abstract Background This study aims to assess the past decade's epidemiology of inflammatory bowel disease (IBD) patients in Türkiye and identify year-to-year…”
Get full text

P521 Correlation between physician disease assessment in Ulcerative Colitis and burden of disease: ICONIC 2-year data of 120 patients in Turkey by Sezgin, O, Atug, O, Gonen, C, Can, G, Duman, A E, Erzin, Y Z, Yurci, M A, Alkim, C, Unal Ozcelik, N G, Yildirim, B, Kayacetin, E, Beyazit, Y, Tayfur Yurekli, O, Kiyici, M

“…Abstract Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD), and the overall burden is increasing at the global level…”
Get full text

P238 THE TOLL-LIKE RECEPTOR (TLR)-4 RELATED A299G AND T399I POLYMORPHISMS IN TURKISH INFLAMMATORY BOWEL DISEASE POPULATION by Akin, H., Özdemir, F.T., Atug, Ö., Tahan, G., Eren, F., Baca, B., Hamzaoglu, I., Hamzaoglu, H.Ö., Tözün, N.

Get full text

P101 Vitamin D deficiency in inflammatory bowel disease patients by Kani, H.T., Demircan, N., Yazici, D., Bicakci, E., Banzragch, M., Atug, O., Over Hamzaoglu, H., Imeryuz, N., Akin, H.

Get full text